NCT04075409View on ClinicalTrials.gov

A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

December 27, 2019

Study Completion Date

December 27, 2019

Conditions
Healthy Japanese Participants
Interventions
DRUG

Padsevonil

Padsevonil will be administered in predefined dosages.

Trial Locations (1)

Unknown

Up0083 001, Tokyo

All Listed Sponsors
lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT04075409 - A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants | Biotech Hunter | Biotech Hunter